Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04293406 · ClinicalTrials.gov registry record
pCHIP: Prostate Cancer Health Impact Program
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 82
- Enrollment target
NCT04293406 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 82 participants.
The verdict
NCT04293406 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 82 participants
- Enrollment target
Study Summary
This project focuses on African American (AA) men and Hispanic/Latino (H/L) men with prostate cancer (PCa) in Brooklyn/Queens catchment. Evidence from randomized clinical trials support the efficacy of decision navigation intervention, with navigated patients showing greater confidence in their decisions about cancer treatment and less regret. The investigators will develop and test the acceptability and feasibility of a decision navigation intervention for AA or H/L men with prostate cancer. The primary aim for this study is to adapt and tailor an evidence based decision navigation intervention for AA and H/L men newly diagnosed with prostate cancer (PCa). The investigators hypothesize that men in the decision navigation intervention arm will report higher levels of decision self-efficacy, less decisional conflict, and regret about their treatment decisions compared to men engaged in standard of care.
Interventions
- OTHER Decision Navigation Intervention (DNI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2024-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04293406
The ClinicalTrials.gov registry entry for NCT04293406 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision Navigation Intervention (DNI) is the first listed.
NCT04293406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04293406 about?
NCT04293406 is a clinical study titled "pCHIP: Prostate Cancer Health Impact Program". This project focuses on African American (AA) men and Hispanic/Latino (H/L) men with prostate cancer (PCa) in Brooklyn/Queens catchment. Evidence from randomized clinical trials support the efficacy of decision navigation intervention, with navigated patients showing greater confidence in their deci...
What is the current status of trial NCT04293406?
This trial is currently terminated. The enrollment target is 82 participants. The study started on 2021-02-10. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT04293406?
The interventions under investigation include: Decision Navigation Intervention (DNI) (OTHER).
Who is sponsoring clinical trial NCT04293406?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.